JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$4.76B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.21B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$3.81B |
| 4 |
Apple
AAPL
|
+$3.39B |
| 5 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$3.1B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total International Bond ETF
BNDX
|
+$2.48B |
| 2 |
S&P Global
SPGI
|
+$2.45B |
| 3 |
Coca-Cola
KO
|
+$1.73B |
| 4 |
Adobe
ADBE
|
+$1.59B |
| 5 |
Schwab Short-Term US Treasury ETF
SCHO
|
+$1.3B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.97% |
| 2 | Technology | 21.69% |
| 3 | Healthcare | 9.58% |
| 4 | Consumer Discretionary | 9.07% |
| 5 | Financials | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
5001
CALL
Relmada Therapeutics
RLMD
$350M
| $256K | ﹤0.01% |
+55,100
| New | +$266K |
2024 Q1
0 quarters
|
|
|
PPTA
5002
Perpetua Resources
PPTA
$2.58B
| $256K | ﹤0.01% |
61,578
+31,944
| +108% | +$105K |
2023 Q2
3 quarters
|
|
5003
KraneShares California Carbon Allowance Strategy ETF
KCCA
$119M
| $256K | ﹤0.01% |
8,935
| – | – |
2023 Q3
2 quarters
|
|
5004
Main Sector Rotation ETF
SECT
$2.95B
| $256K | ﹤0.01% |
5,072
| – | – |
2023 Q4
1 quarter
|
|
5005
Pacer Trendpilot US Large Cap ETF
PTLC
$3.39B
| $255K | ﹤0.01% |
5,353
-1,672
| -24% | -$75.8K |
2022 Q2
7 quarters
|
|
|
NREF
5006
NexPoint Real Estate Finance
NREF
$291M
| $255K | ﹤0.01% |
17,779
+7,270
| +69% | +$106K |
2021 Q1
12 quarters
|
|
5007
PUT
Ocular Therapeutix
OCUL
$1.61B
| $255K | ﹤0.01% |
+28,000
| New | +$199K |
2024 Q1
0 quarters
|
|
|
CBIO
5008
Crescent Biopharma
CBIO
$504M
| $254K | ﹤0.01% |
846
+830
| +5,188% | +$248K |
2022 Q3
6 quarters
|
|
|
ALLK
5009
DELISTED
Allakos
ALLK
| $254K | ﹤0.01% |
201,192
+153,450
| +321% | +$238K |
2018 Q3
22 quarters
|
|
5010
Hingham Institution for Saving
HIFS
$629M
| $253K | ﹤0.01% |
1,450
-2,262
| -61% | -$398K |
2016 Q3
30 quarters
|
|
5011
Bitwise Bitcoin ETF
BITB
$3.17B
| $253K | ﹤0.01% |
+6,530
| New | +$195K |
2024 Q1
0 quarters
|
|
|
IAUX
5012
i-80 Gold Corp
IAUX
$1.39B
| $252K | ﹤0.01% |
187,781
+39,206
| +26% | +$56.8K |
2022 Q4
5 quarters
|
|
5013
Vera Bradley
VRA
$146M
| $251K | ﹤0.01% |
36,953
+7,147
| +24% | +$52.4K |
2022 Q4
5 quarters
|
|
|
PSTX
5014
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $250K | ﹤0.01% |
78,525
+32,402
| +70% | +$108K |
2020 Q3
14 quarters
|
|
5015
CALL
Emerson Electric
EMR
$90B
| $250K | ﹤0.01% |
2,200
-70,500
| -97% | -$7.24M |
2021 Q1
12 quarters
|
|
5016
Baytex Energy
BTE
$3.28B
| $249K | ﹤0.01% |
68,492
+25,792
| +60% | +$83.6K |
2023 Q1
4 quarters
|
|
5017
Northern Trust International Quality Dividend ETF
IQDF
$1.15B
| $248K | ﹤0.01% |
10,269
+3,867
| +60% | +$90.8K |
2022 Q3
6 quarters
|
|
5018
Heritage Insurance Holdings
HRTG
$1.02B
| $246K | ﹤0.01% |
23,145
+6,319
| +38% | +$44.5K |
2017 Q2
27 quarters
|
|
5019
FT Vest Growth-100 Buffer ETF June
QJUN
$747M
| $246K | ﹤0.01% |
+9,659
| New | +$240K |
2024 Q1
0 quarters
|
|
|
GOOS
5020
Canada Goose Holdings
GOOS
$746M
| $246K | ﹤0.01% |
20,389
-37,693
| -65% | -$468K |
2017 Q2
27 quarters
|
|
5021
Franklin FTSE Australia ETF
FLAU
$213M
| $246K | ﹤0.01% |
8,523
-756
| -8% | -$21.1K |
2022 Q4
5 quarters
|
|
5022
Granite Ridge Resources
GRNT
$608M
| $245K | ﹤0.01% |
37,754
-123,035
| -77% | -$722K |
2023 Q1
4 quarters
|
|
5023
iShares US Oil Equipment & Services ETF
IEZ
$355M
| $245K | ﹤0.01% |
10,365
+5,721
| +123% | +$122K |
2013 Q2
43 quarters
|
|
5024
Capital Group Global Growth Equity ETF
CGGO
$12.1B
| $245K | ﹤0.01% |
8,500
+7,003
| +468% | +$191K |
2023 Q4
1 quarter
|
|
5025
FibroBiologics
FBLG
$7.86M
| $245K | ﹤0.01% |
+1,132
| New | +$272K |
2024 Q1
0 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2024 Portfolio in Review
As of Q1 2024, JP Morgan Chase held 8,132 positions worth $1.18T, up 14% from $1.04T the previous quarter. Its ten largest holdings account for 21% of the portfolio.
JP Morgan Chase deployed $48.7B of net new capital in Q1 2024, opening 625 new positions and adding to 3,255 existing holdings. Its largest new stake was Flutter Entertainment: 1,314,201 shares worth $260M.
By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, down from 26% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Vanguard Total International Bond ETF, an estimated $2.48B trimmed.
- JP Morgan Chase's largest Q1 2024 buy was Flutter Entertainment: 1,314,201 shares worth $260M.
- JP Morgan Chase added most to Vanguard S&P 500 ETF in Q1 2024, an estimated $4.76B increase.
- JP Morgan Chase's biggest Q1 2024 reduction was Vanguard Total International Bond ETF, cutting an estimated $2.48B.
- JP Morgan Chase fully exited BlackRock Flexible Income ETF in Q1 2024, selling an estimated $139M.
- JP Morgan Chase's ten largest holdings make up 21% of its $1.18T portfolio in Q1 2024.
- JP Morgan Chase opened 625 new positions and closed 764 in Q1 2024.
- JP Morgan Chase's portfolio value rose 14% quarter-over-quarter to $1.18T.
Based on JP Morgan Chase's 13F filing for Q1 2024, filed 10 May 2024.